Compare
biote Corp. vs Mannatech Inc
| Latest fiscal year | biote Corp. BTMD | Mannatech Inc MTEX |
|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 |
| Revenue | $192.22M | $108.04M |
| Revenue growth (YoY) | -2.5% | -8.3% |
| Gross margin | n/a | 74.9% |
| Operating margin | 18.5% | -0.4% |
| Net margin | 14.1% | -14.1% |
| Net income | $27.05M | -$15.21M |
| EPS (Diluted) | $0.74 | -$8.00 |
| Operating cash flow | $35.19M | -$2.96M |
| Free cash flow | $30.18M | -$4.32M |
| Cash & equivalents | $24.12M | $6.18M |
| Total assets | $107.61M | $29.99M |
| Total liabilities | $158.01M | $35.22M |
| Shareholders' equity | -$58.54M | -$5.22M |
| Return on year-end equity | n/a | n/a |
| Shares outstanding | n/a | 1.90M |
Revenue, most recent five fiscal years
| Fiscal year | biote Corp. | Mannatech Inc |
|---|---|---|
| Latest | $192.22M Ended 2025-12-31 | $108.04M Ended 2025-12-31 |
| 1 year earlier | $197.19M Ended 2024-12-31 | $117.87M Ended 2024-12-31 |
| 2 years earlier | $185.36M Ended 2023-12-31 | $131.96M Ended 2023-12-31 |
| 3 years earlier | $164.96M Ended 2022-12-31 | $137.21M Ended 2022-12-31 |
| 4 years earlier | $139.40M Ended 2021-12-31 | $159.76M Ended 2021-12-31 |